Transfer factor: A potential agent for immunotherapy of cancer

C. Richard Meier, Albert F. LoBuglio

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Transfer factor (TF) is an extract from human leukocytes which has been shown to transfer specific skin test reactivity to previously nonreactive human recipients, and to produce measurable increases in in Vitro tests of lymphocyte activity. The results of the experimental use of TF as an immunotherapeutic agent for cancer are reviewed. TF therapy has been associated with tumor regression, temporary stabilization or reduced need for other treatment modalities in several reported cancer patients, and may have value as an adjuvant therapy in certain malignancies. However, most of the reports involve uncontrolled studies, and no agreement exists about the definition of TF donors. Controlled studies and the use of well characterized TF donors are essential before any conclusions can be drawn about the value of TF in the therapy of cancer and other diseases.

Original languageEnglish (US)
Pages (from-to)617-621
Number of pages5
JournalWorld Journal of Surgery
Volume1
Issue number5
DOIs
StatePublished - Sep 1977
Externally publishedYes

Fingerprint

Transfer Factor
Immunotherapy
Neoplasms
Therapeutics
Skin Tests
Leukocytes
Lymphocytes

ASJC Scopus subject areas

  • Surgery

Cite this

Transfer factor : A potential agent for immunotherapy of cancer. / Meier, C. Richard; LoBuglio, Albert F.

In: World Journal of Surgery, Vol. 1, No. 5, 09.1977, p. 617-621.

Research output: Contribution to journalArticle

Meier, C. Richard ; LoBuglio, Albert F. / Transfer factor : A potential agent for immunotherapy of cancer. In: World Journal of Surgery. 1977 ; Vol. 1, No. 5. pp. 617-621.
@article{47362d2604b741d1bc085c4fc7aca42e,
title = "Transfer factor: A potential agent for immunotherapy of cancer",
abstract = "Transfer factor (TF) is an extract from human leukocytes which has been shown to transfer specific skin test reactivity to previously nonreactive human recipients, and to produce measurable increases in in Vitro tests of lymphocyte activity. The results of the experimental use of TF as an immunotherapeutic agent for cancer are reviewed. TF therapy has been associated with tumor regression, temporary stabilization or reduced need for other treatment modalities in several reported cancer patients, and may have value as an adjuvant therapy in certain malignancies. However, most of the reports involve uncontrolled studies, and no agreement exists about the definition of TF donors. Controlled studies and the use of well characterized TF donors are essential before any conclusions can be drawn about the value of TF in the therapy of cancer and other diseases.",
author = "Meier, {C. Richard} and LoBuglio, {Albert F.}",
year = "1977",
month = "9",
doi = "10.1007/BF01556190",
language = "English (US)",
volume = "1",
pages = "617--621",
journal = "World Journal of Surgery",
issn = "0364-2313",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Transfer factor

T2 - A potential agent for immunotherapy of cancer

AU - Meier, C. Richard

AU - LoBuglio, Albert F.

PY - 1977/9

Y1 - 1977/9

N2 - Transfer factor (TF) is an extract from human leukocytes which has been shown to transfer specific skin test reactivity to previously nonreactive human recipients, and to produce measurable increases in in Vitro tests of lymphocyte activity. The results of the experimental use of TF as an immunotherapeutic agent for cancer are reviewed. TF therapy has been associated with tumor regression, temporary stabilization or reduced need for other treatment modalities in several reported cancer patients, and may have value as an adjuvant therapy in certain malignancies. However, most of the reports involve uncontrolled studies, and no agreement exists about the definition of TF donors. Controlled studies and the use of well characterized TF donors are essential before any conclusions can be drawn about the value of TF in the therapy of cancer and other diseases.

AB - Transfer factor (TF) is an extract from human leukocytes which has been shown to transfer specific skin test reactivity to previously nonreactive human recipients, and to produce measurable increases in in Vitro tests of lymphocyte activity. The results of the experimental use of TF as an immunotherapeutic agent for cancer are reviewed. TF therapy has been associated with tumor regression, temporary stabilization or reduced need for other treatment modalities in several reported cancer patients, and may have value as an adjuvant therapy in certain malignancies. However, most of the reports involve uncontrolled studies, and no agreement exists about the definition of TF donors. Controlled studies and the use of well characterized TF donors are essential before any conclusions can be drawn about the value of TF in the therapy of cancer and other diseases.

UR - http://www.scopus.com/inward/record.url?scp=0017696466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017696466&partnerID=8YFLogxK

U2 - 10.1007/BF01556190

DO - 10.1007/BF01556190

M3 - Article

C2 - 272085

AN - SCOPUS:0017696466

VL - 1

SP - 617

EP - 621

JO - World Journal of Surgery

JF - World Journal of Surgery

SN - 0364-2313

IS - 5

ER -